Aktis Oncology Inc
AKTS
NASDAQ
Biotechnology
$24.93
USD
+1.14 (+4.79%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.33B
Volume 229.6K
Price Target
$35.00 – $40.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $40.00 and a min estimate of $35.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$37.50
+$4.5 vs prior
Implied Upside
+50.4%
+18.1% vs prior
Analyst Covering
2
+1 vs prior period
Consensus
Strong Buy
Improved vs prior
Signal Quality
Consensus Freshness
67%
Most ratings are recent - from the last 3 months
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Strong Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Christopher Raymond | Piper Sandler | Strong Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Robert Burns | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
PURR
Hyperliquid Strategies Inc
$6.68
▼ -2.0%
ORIC
Oric Pharmaceuticals Inc
$13.87
▲ +1.1%
INBX
Inhibrx Biosciences Inc
$88.37
▼ -8.9%
CGEM
Cullinan Therapeutics Inc
$20.34
▲ +3.6%
TYRA
Tyra Biosciences Inc
$25.29
▲ +1.1%
NVAX
Novavax Inc
$8.05
▼ -1.1%
AVBP
ArriVent BioPharma Inc
$29.51
▼ -1.6%
MGTX
MeiraGTx Holdings PLC
$13.52
▲ +6.7%
GLUE
Monte Rosa Therapeutics Inc
$15.50
▼ -2.1%
VIR
Vir Biotechnology Inc
$9.24
▲ +2.7%